Genpact price target lowered to $41 from $46 at BMO Capital

BMO Capital analyst Keith Bachman lowered the firm’s price target on Genpact to $41 from $46 and keeps a Market Perform rating on the shares. The company’s recent bookings growth raises the firm’s interest level, but it is not compelled to move to a more constructive stance given uncertainty of estimates and the ongoing demand uncertainty, the analyst tells investors in a research note.